Resultados de la búsqueda 331-340 of 1915 for GLP-1 agonists
Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
REVOLUTION will be a multicenter registry enrolling approximately 2,500 patients. Additional patients limited to those with EGFR mutations may be enrolled ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy must ...
The purpose of this study is to monitor T cell responses from patients with advanced cancer who are being treated with an anti-PD (programmed death)-1 ...
The purpose of this study is to measure objective functional activity and gait and trunk stability in spinal deformity patients utilizing motion analysis ...
Recurrent primary hyperparathyroidism in a patient with multiple endocrine neoplasia type 1 · Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?
Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri, Dec 05, 2025. Amanda Burnett · Bariatric Surgery & Weight Loss: Meet others & Share.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?